October 13th, 2015|
A man’s sex drive, muscle mass, and energy can decrease as he ages due to a decrease in a hormone called testosterone. Many men undergo hormone replacement therapy to ward off these symptoms of aging. However, the drug injury attorneys at Ferrer, Poirot & Wansbrough explain that such treatments can put men at an increased risk of suffering adverse cardiac events.
Testosterone therapy heart attacks came to light when reports began to surface that men were suffering cardiac events after beginning testosterone therapy drugs. These reports prompted a team of researchers from Harvard Medical School to study the potential risks. They found the chances of an older male having a heart attack or stroke while undergoing testosterone therapy can be as much as 30 times higher than that of a man not taking these medications. This is because testosterone can cause an overproduction of red blood cells, which can lead to the development of blood clots.
These findings have led to a number of lawsuits against the makers of testosterone replacement medications. Now, according to CBS News, a large number of those cases will soon be heard in Chicago.
At Ferrer, Poirot & Wansbrough, we recognize the struggles many men undergoing testosterone therapy have faced along their journey to recovery. That’s why our drug injury attorneys are hopeful a decision in these cases will help bring a sense of closure to the victims in these matters.
September 8th, 2015|
For years, some young male patients using Risperdal® have claimed the medication caused them to develop gynecomastia—a condition in which males develop excessive amounts of breast tissue. Janssen Pharmaceuticals, Inc. and Johnson & Johnson, the makers of the drug, have denied these allegations, but now there may be proof that the medication’s manufacturer hid data indicating there may be a link between Risperdal and gynecomastia.
The Risperdal® drug injury lawyers at Ferrer, Poirot & Wansbrough explain that new data was discovered when the results of a study conducted in 2003 were reexamined. Investigators found that certain data and tables in preliminary versions of the study’s conclusions were not present when the study was submitted to the U.S. Food and Drug Administration (FDA) as part of the drug approval process.
According to Forbes, early versions of the study showed a large number of young male patients using Risperdal had increased levels of hormones that play a role in breast development. However, this data was not present when the study was submitted to the FDA. Now, the drug makers behind Risperdal are being accused of hiding the data about Risperdal side effects to get the drug approved and boost sales.
At Ferrer, Poirot & Wansbrough, our drug injury lawyers are hopeful that officials investigate these allegations further.
June 30th, 2015|
Painkiller overdoses are one of the leading causes of accidental drug injury and death in the United States today. One of the most common drugs involved in these incidents is a powerful narcotic painkiller known as Fentanyl. In fact, the painkiller is known to be involved in more than 1,000 U.S. deaths per year.
The drug is administered by placing a sticky patch containing the drug to the skin. The drug is then absorbed through the skin and into the bloodstream. The only way to determine the dosage is to adjust the size of the patch. Fentanyl patch side effects can include nausea, decreases in respiration, slowed heart rate, and death.
Despite these risks, drug manufacturers continue to market dosages of the drug. According to Pharmacy Times, one maker of the medication—Mylan, Inc.—recently announced it would begin distributing three new dosages of the drug. Currently, the drug is dispensed in 12 mcg/hr, 25 mcg/hr, 50 mcg/hr, 75 mcg/hr, and 100 mcg/hr dosages. Now, patients and doctors will have 37.5 mcg/hr, 62.5 mcg/hr, and 87.5 mcg/hr options as well.
With Fentanyl so readily available, some communities are experiencing an epidemic of drug overdoses linked to the medication. This has forced some Canadian cities to adopt policies that require patients taking Fentanyl to return used patches to their pharmacist before new ones can be distributed.
Our drug injury attorneys at Ferrer, Poirot & Wansbrough are aware of the serious dangers that Fentanyl can pose. That’s why we’re hopeful more steps are taken to keep patients safe.
December 9th, 2014|
When a patient is harmed as the result an unsafe or recalled drug, they may be entitled to seek compensation for damages by filing a drug injury lawsuit. There are several steps to the multidistrict litigation (MDL) process through which many drug injury and defective medical device claims are handled.
Your attorney files your claim after gathering evidence related to your drug injury. Once your case is consolidated alongside other similar claims related to the same drug, the case will proceed through three steps:
- Discovery- This is an opportunity for plaintiffs’ attorneys and drug company lawyers to exchange information so that both sides can thoroughly consider and understand all aspects of the case.
- Pretrial- After gathering all the necessary information, both sides present their case to a single judge assigned to the MDL.
- Settlement Conferences- After hearing arguments, the judge will attempt to mediate a settlement between the plaintiffs’ attorneys assigned to the MDL and the drug company lawyers. If a settlement is reached, each plaintiff receives a settlement based upon his or her injuries. If an agreement cannot be reached between the two sides, individual cases are sent back to the courts where they were filed for trial.
At Ferrer, Poirot & Wansbrough, we understand how drug injuries affect victims’ lives. That’s why our drug injury attorneys are here to answer any questions you may have if you or a loved one has been harmed as the result of a recalled or dangerous drug. Call us to learn more about how we can help at (800) 210-8503.
November 18th, 2014|
It’s important to know that taking certain weight loss or muscle building products can lead to workout supplement health risks—and many of these dangerous products make their way back on to the market, even after being recalled.
An article from Food Safety News explains the study examined a total of 27 of the 274 workout and dietary supplements recalled between 2009-2012. They concluded eighteen products contained ingredients considered adulterants in the United States. These ingredients include:
- Anabolic Steroids
Despite these products containing undeclared ingredients, an estimated 68 percent of the products remained on the shelf six months after being recalled. Officials say the reason for the lack of action is the fact the law doesn’t properly regulate the dietary and workout supplement industries.
So what should you do if you’ve been harmed by a dietary or workout supplement? The drug injury attorneys with Ferrer, Poirot & Wansbrough suggest discussing your legal rights with an attorney. Our legal team is available to speak with you about your injuries anytime—just dial (800) 210-8503.
October 28th, 2014|
One of the most common causes for drug injuries in the United States today is medication errors, which occur when patients are given too much or too little of a drug—or the wrong medication altogether.
And according to new research, these types of drug injuries may be more common than you think, especially among children. An article from Time magazine features a new study showing that one in eight children will be victims of medication errors this year alone.
Researchers examined medical records collected over a decade and discovered more than 200,000 drug errors reported to poison control centers each year. The victims in roughly one-third of those cases were children under age 6. Almost 82 percent of the incidents involved liquid medications, while almost 15 percent of injuries were caused by tablets or capsules.
The research team that conducted the study suggested that drug makers improve the labeling and dosage directions for their products.
The drug injury attorneys with Ferrer, Poirot & Wansbrough have seen the devastating results that medication errors can have and are hopeful this study prompts action to better protect patients from harm.
September 9th, 2014|
Football season is upon us again, and for many players, parents, and coaches, so is the concern over concussions and other traumatic brain injuries (TBIs). While there are many actions that can be taken to prevent these injuries, the drug injury attorneys at the law firm of Ferrer, Poirot & Wansbrough would like to remind the public that taking a workout supplement is not one of them.
The U.S. Food and Drug Administration (FDA) recently stated some companies have begun marketing “untested, unproven, and possibly dangerous” products that are said to help prevent, treat, and even cure TBIs.
The problem came to light after the agency discovered a company marketing a product as an effective way to cut the recovery time after suffering a TBI. The product was even endorsed by a player in the National Football League. The FDA took action to prevent the company from continuing to market the product, but officials say preventing the use of these products comes down to public awareness about workout supplement health risks.
The FDA is asking athletes to avoid using supplements as a means of treating a TBI. Instead, the agency says seeking medical attention from a doctor and taking plenty of time to recuperate is the best way to treat a TBI. Athletes can also prevent TBIs by using proper technique when playing.
September 2nd, 2014|
Each year, hundreds of thousands of patients become drug injury victims or are harmed by defective medical devices. Most experts agree that more transparency within the medical field is one of the best ways to reduce the number of adverse health events patients suffer due to negligence or error. This is why the U.S. Food and Drug Administration (FDA) has launched a new database known as OpenFDA.
Officials say the database, which currently holds more than 3 million documents, gives the public access to reports and records regarding incidents of patient harm. While OpenFDA is still in it’s testing phase, many believe the information provided will lead to faster action being taken when problems with specific medical products are identified.
The new system will also create a more efficient means for data to be analyzed by researchers, providing a greater insight into focused areas of medicine.
At Ferrer, Poirot & Wansbrough, our drug injury attorneys are excited about the FDA’s new system and are hopeful that it’s successful in providing a greater scope of information about the medical industry to the American people.
July 1st, 2014|
While purchasing a generic version of a drug may be a cost effective way to get the medications you need, doing so may present some serious risks. This is because generic drugs are not held to the same manufacturing standards as brand name versions of medications.
The U.S. Food and Drug Administration has a stringent set of rules brand name drug makers must follow when creating their products. These standards include precise measurements of ingredients as well as limits on fillers that can be placed into the product. This creates uniformity to the products that are manufactured.
Generic drugs are made under a different set of standards though, that allow makers to use small variations in the amount of active ingredient that is placed in the drug. This can cause serious hazards to the patient, including the risk of suffering a drug injury.
Take the case that has been brought to light by a doctor from the Cleveland Clinic. In an article from the New York Times Syndicate, the cardiologist explains he saw numerous patients taking a generic version of the drug, AstraZeneca, suffering chest pains. When patients were put back on the brand name version of the drug, the symptoms disappeared.
Now, the two Indian companies who make the generic versions of the drug have announced the voluntary recall of 100,000 units of product due to the medications failing to dissolve and absorb into the patients’ bodies properly.
Problems like these are why the drug injury attorneys with Ferrer, Poirot & Wansbrough encourage patients to take the brand name version of medications they are prescribed. If you have suffered a drug injury after taking a generic version of a medication though, the firm encourages you to seek qualified legal representation to ensure your potential rights to compensation are protected under the law.
May 20th, 2014|
Medications can be an extremely effective way to treat medical conditions, but sometimes side effects can lead to drug injuries. One drug that has been linked to a number of health conditions is Risperdal.
The medication is prescribed to treat certain mental disorders, such as autism spectrum disorder and schizophrenia, but the list of Risperdal side effects is extensive. Some patients have reported abnormal weight gain due to increased appetite caused by the drug and others have stated use of the medication has resulted in involuntary movements in their bodies and limbs.
The Simons Foundation Autism Research Initiative says one of the more devastating results of using Risperdal is the development of a condition known as gynecomastia. This occurs when adolescent male patients develop abnormally large breasts because of hormonal changes the drug can cause.
Since the discovery of these side effects, warnings have been placed on the labels of the product, but many individuals were affected prior to the updates being made. These patients may be entitled to compensation for damages the drug caused.
At Ferrer, Poirot & Wansbrough, our drug injury attorneys are here to answer your questions. If you or a loved one have been harmed by a medication, call us today at (800) 210-8503 or fill out a free online consultation form on our website to see what we can do for you.